Full history for every metric is available with a Kvantra account
Cellular Goods PLC (CBX.L)
Key financial summary
Financials in GBP| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating profit | £m | -3 | -3 | |||||
| Net profit | £m | - | -0 | -0 | -3 | -6 | -3 | -3 |
| EPS reported | £ | -0.01 | -0.01 | |||||
| Operating cashflow per share | £ | -0.00 | -0.00 | |||||
| Capex per share | £ | 0.00 | 0.00 | |||||
| FCF per share | £ | -0.00 | -0.00 | |||||
| Free cash flow | £m | -3 | -3 | |||||
| Net debt | £m | -2 | -2 | |||||
| Book value equity | £m | 2 | 2 | |||||
| Book value per share | £ | 0.00 | 0.00 | |||||
| Number of shares | m | 537.96 | 589.91 | |||||
| DPS (TTM paid) | £ | 0.00 | 0.00 |
Financial summary
Financials in GBP| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.37 | 0.99 | |||||
| P/S LTM | x | 46.01 | 33.41 | |||||
| P/FCF LTM | x | -1.18 | -0.86 | |||||
| EV/EBITDA LTM | x | -0.40 | -0.14 | |||||
| EV/Sales LTM | x | 19.64 | 7.04 | |||||
| Earnings Yield LTM | % | -107.00% | -164.94% | |||||
| FCF Yield | % | -84.90% | -115.89% | |||||
| Quality | ||||||||
| ROE | % | -146.27% | -93.03% | |||||
| ROIC | % | -147.33% | -147.33% | |||||
| Operating margin | % | -4958.3% | -4958.3% | |||||
| Gross margin | % | 61.63% | 61.63% | |||||
| FCF/Sales | % | -3905.7% | -3905.7% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +132.62% | +132.62% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | - | - | |||||
| Net Debt/EBITDA | x | 0.53 | 0.53 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | -57.31% | -78.92% | |||||
| Net debt/Equity | x | -0.78 | -0.78 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
Cellular Goods PLC, along with its associated companies, specializes in creating and distributing consumer products infused with biosynthetic cannabinoids throughout the United Kingdom. Their portfolio includes cannabinoid-based solutions designed for both skincare applications and oral consumption. These items are available for purchase via traditional retailers, directly to customers through their proprietary website, and across various online platforms. Established in 2018, the organization was originally named Leaf Studios PLC, subsequently adopting the Cellular Goods PLC moniker in September 2020, and maintains its headquarters in London, UK.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Cellular Goods PLC (CBX.L)
Cellular Goods PLC, along with its associated companies, specializes in creating and distributing consumer products infused with biosynthetic cannabinoids throughout the United Kingdom. Their portfolio includes cannabinoid-based solutions designed for both skincare applications and oral consumption. These items are available for purchase via traditional retailers, directly to customers through their proprietary website, and across various online platforms. Established in 2018, the organization was originally named Leaf Studios PLC, subsequently adopting the Cellular Goods PLC moniker in September 2020, and maintains its headquarters in London, UK.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free